BCL2 and cancer: These data indicate that GSPs treatment can alter the protein levels of key members of the Bcl-2 family in a manner that favors an increase in the ratio of Bax:Bcl-2, which may contribute to the susceptibility of cancer cells to GSPs-induced apoptosis (Figure 4C) [36].